Immunodystrophism: Evidence for a Novel Alloimmune Hypothesis for Recurrent Pregnancy Loss Involving Th1-Type Immunity to Trophoblast

Joseph A. Hill III; Bum Chae Choi

doi:10.1055/s-2000-13730

Seminars in Reproductive Medicine, Table of Contents

Semin Reprod Med 2000; 18(4): 401-406
DOI: 10.1055/s-2000-13730

Immunodystrophism: Evidence for a Novel Alloimmune Hypothesis for Recurrent Pregnancy Loss Involving Th1-Type Immunity to Trophoblast

Joseph A. Hill III¹ , Bum Chae Choi²

¹The Center for Reproductive Medicine and the Fearing Research Laboratory, Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, Massachusetts
²Recurrent Pregnancy Loss Center, Creation and Love Women's Hospital, Kwang-ju, Korea

Abstract

ABSTRACT

Pregnancy loss is the most common complication of pregnancy. Recurrent pregnancy loss occurs in approximately 1% of pregnant women. Many immunologic theories have been proposed but have not withstood rigorous analysis. A novel alloimmune hypothesis involving T helper (Th) 1-type immunity to trophoblast is the latest theory proposed for recurrent pregnancy loss. The basic hypothesis is, in the decidua there are myriad of antigen presenting cells and other immune response cells. In response to trophoblast invasion, these cells may become activated. A by-product of this activation is the secretion by these cells of either a predominant Th1 or Th2 cytokine profile. In cases where a Th1 cytokine profile predominates, chiefly, interferon-gamma, tumor necrosis factor, or interleukin-12, these cytokines may directly or indirectly be detrimental to early placental cell differentiation and growth and toxic to embryo development. Further evidence for this novel hypothesis comes from recent findings of a genetic predisposition for a vigorous Th1 cytokine response in these women due to a polymorphism in the IL1B promoter region. Further studies are needed to substantiate definitive causative links between Th1-immunity to trophoblast and recurrent pregnancy loss. Clinical trials are also needed to determine the best therapy for this disorder.

KEYWORD

Trophoblast - T-helper 1-type immunity - recurrent pregnancy loss - immunodystropism

Full Text

References

REFERENCES

1 United States Department of Health and Human Services. Reproduction Impairment Among Married Couples: US Vital and Health Statistics. National Center for Health Statistics Series 23 1992: 5-31
2 Harlop S, Shioino P H, Ramcharon S. A life table of spontaneous abortions and the effects of age, parity and other variables. In: Porter IH, ed. Human Embryonic and Fetal Death New York: Academic Press 1980: 145-154
3 Wilcox A J, Weinberg C R, O'Connor J F. Incidence of early loss of pregnancy. N Engl J Med . 1988; 319 189-194
4 Regan L. Recurrent miscarriage. Br Med J . 1991; 302 543-544
5 Medawar P B. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol . 1953; 7 320-338
6 Hill J A. Recurrent pregnancy loss. In: Creasey RK, Resnick R, eds. Maternal-Fetal Medicine Philadelphia: WB Saunders 1998: 423-443
7 King A, Babcock C, Sharkey A. Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J Immunol . 1996; 156 2068-2076
8 Kovats S, Main E K, Librach C, Stubblebine M, Fisher S J H U, DeMars R. A class I antigen HLA-G₁ expressed in human trophoblasts. Science . 1990; 248 220-223
9 LeBouteller P, Lenfant F. Antigen presenting function(s) of the nonclassical HLA-E, -F and -G class I molecules: the beginning of a story. Res Immunol . 1996; 157 4741-4745
10 Anderson D J, Berkowitz R L. Gamma interferon enhances expression of class I MHC antigens in the weakly HLA (+) human choriocarcinoma cell line BeWO but does not induce MHC expression in the HLA (-) choriocarcinoma cell line JAR. J Immunol . 1995; 135 2498-2500
11 Hill J A, Melling G C, Johnson P M. Immunohistochemical studies of human uteroplacental tissues from first trimester spontaneous abortion. Am J Obstet Gynecol . 1995; 173 90-96
12 Pazmany L, Mandelboim O, Vales-Gomez M, Davis D M, Reyburn H T, Strominger J L. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science . 1996; 274 792-795
13 Mandelboim O, Reyburn H T, Shen E G. The binding site of NK receptors on HLA-C molecules. Immunology . 1997; 6 341-350
14 Loke Y W, King A. Human Implantation: Cell Biology and Immunology. Cambridge: Cambridge University Press; 1995
15 Critchley H O, Kelly R W, Lea R G, Drug T A, Jones R L, Baird D T. Sex steroid regulation of leukocyte traffic in human decidua. Hum Reprod . 1996; 11 2257-2262
16 Schust D, Anderson D J, Hill J A. Progesterone induced immunosuppression is not mediated through the progesterone receptor. Hum Reprod . 1996; 11 980-985
17 Tabibzadeh S. Proliferative activity of lymphoid cells in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab . 1990; 70 437-443
18 Tabibzadeh S. Human endometrium: an active site of cytokine production and action. Endocrinol Rev . 1991; 12 272-290
19 Bermas B L, Hill J A. Proliferation responses to recall antigens are associated with pregnancy outcome in women with a history of recurrent spontaneous abortion. J Clin Invest . 1997; 100 1330-1334
20 Hill J A, Hsia S, Doran D W, Bryans Jr I C. Natural killer cell activity and antibody dependent cell-mediated cytotoxicity in pre-eclampsia. J Reprod Immunol . 1986; 9 205-215
21 Purcell D F, McKenzie I F, Lublin D M, Johnson P M, Atkinson J P. The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system and trophoblast leucocyte-common (TLX) antigen are CD46. Immunology . 1990; 70 155-161
22 ACOG Educational and Practice Bulletin 244. Antiphospholipid syndrome. Fertility 1998
23 Rocklin R E, Kitzmiller J R, Carpenter C B, Garovoy M R, David J R. Maternal-fetal relation: absence of an immunologic blocking factor from serum of women with chronic abortions. N Engl J Med . 1976; 295 1209-1213
24 Sargent I L, Wilkins T, Redman C WG. Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet . 1994; 2 1099-1104
25 Rocklin R E, Kitzmiller J R, Garvey M R. Maternal-fetal relation: further characterization of an immunologic blocking factor that develops during pregnancy. Clin Immunol Immunopathol . 1982; 22 305-315
26 Amos D B, Kostyn D D. HLA: a central immunologic agency of man. Adv Hum Genet . 1980; 10 137-141
27 Katano K, Aoki K, Ogasawara M. Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera. Lupus . 1995; 4 304-308
28 Rodger C. Lack of a requirement for a maternal humoral immune response to establish and maintain successful allogenic pregnancy. Transplantation . 1985; 40 372-375
29 Hill J A. Implications of cytokines in male and female sterility. In: Chaouat GA, Mowbray JF, eds. Cellular and Molecular Biology of the Materno-Fetal Relationship Paris: INSERM/John Libbey Eurotext 1991: 123-129
30 Hill J A, Polgar K, Harlow B L, Anderson D J. Evidence of embryo and trophoblast toxic cellular immune responses in women with recurrent spontaneous abortion. Am J Obstet Gynecol . 1992; 166 1044-1052
31 Yamada H, Polgar K, Hill J A. Cell mediated immunity to trophoblast antigens in women with recurrent spontaneous abortion. Am J Obstet Gynecol . 1994; 170 1339-1344
32 Hill J A, Anderson D J, Polgar K. T helper I-type cellular immunity to trophoblast in women with recurrent spontaneous abortion. JAMA . 1995; 273 1933-1936
33 Wegmann T G, Lin H, Gilbert L, Mosmann J R. Bi-directional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon?. Immunol Today . 1993; 14 353-356
34 Raghupathy R. Th1-immunity is incompatible with successful pregnancy. Immunol Today . 1997; 18 478-482
35 Cohen P E, Pollard J W. Cytokines and growth factors in reproduction. In: Bronson RA, Alexander NJ, Anderson D, Branch DW, Kutteh WH, eds. Reproductive Immunology Cambridge: Blackwell Sciences 1996: 52-105
36 Klentzeris L D, Bulmer J N, Warren M A, Morrison L, Li T C, Cooke I D. Lymphoid tissue in the endometrium of women with unexplained infertility: morphometric and immunohistochemical aspect. Hum Reprod . 1994; 9 646-652
37 Lachapelle M H, Miran P, Hemmings R, Roy D K. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion: altered profile in pregnancy outcome. J Immunol . 1996; 156 4027-4034
38 Vassilisou N, Searlel R F, Bulmer N N. Elevated expression of activin molecules by decidual lymphocytes in women suffering spontaneous early pregnancy loss. Hum Reprod . 1999; 14 1194-1200
39 Quack K C, Vassiliadou N, Pudney J, Anderson D J, Hill J A. Leukocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortion. Hum Reprod 2001. In press.